Olaparib Tablets Maintenance Monotherapy Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy

Clinical trial NCT03534453 · COMPLETED

Trial details

NCT number: NCT03534453
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Relapsed Ovarian Cancer Following Complete or Partial Response to Platinum Based Chemotherapy Platinum Sensitive

Start date: 2018-05-29
Primary completion: 2025-01-27
Enrollment: 229

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.